Kimberly Lee | Senior Vice President of Corporate Communications and Investor Relations |
RA Session II | President, Founder, and Chief Executive Officer |
Suyash Prasad | Chief Medical Officer and Head-R&D |
Kamran Alam | Chief Financial Officer |
Fred Porter | Chief Technical Officer |
Salveen Richter | Goldman Sachs |
Raju Prasad | William Blair |
Eun Yang | Jefferies |
Welcome to the Taysha Gene Therapies First Quarter 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a brief question-and-answer session.
As a reminder, this call is being recorded today, May 11, 2021. I will now turn the call over to Dr.